Kenji Nagasaka
Ome, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
JCS 2026 Guideline on Management of Large Vessel Vasculitis.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: March 22, 2026
Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel Vasculitis.
Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel Vasculitis.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: February 15, 2026
Genetic associations of eosinophilic granulomatosis with polyangiitis in the Japanese population: exploring similarities and differences with European populations.
Journal: RMD open
Published: December 15, 2025
Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping review.
Journal: Modern rheumatology
Published: September 12, 2025
Updated treatment approaches for eosinophilic granulomatosis with polyangiitis: A systematic scoping review.
Journal: Modern rheumatology
Published: September 12, 2025
Nation wide cohort study of Japanese patients with ANCA associated vasculitis using rituximab Effectiveness and safety after two years.
Journal: Modern rheumatology
Published: November 26, 2024
Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of microscopic polyangiitis and granulomatosis with polyangiitis: The 2023 update - secondary publication.
Journal: Modern rheumatology
Published: June 23, 2023
Evaluation of Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitis compared to ACR/EULAR 2022 classification criteria.
Journal: Modern rheumatology
Published: March 01, 2023
Association of HLA-class II alleles with risk of relapse in myeloperoxidase-antineutrophil cytoplasmic antibody positive vasculitis in the Japanese population.
Journal: Frontiers in immunology
Published: December 08, 2022
Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 months.
Journal: Modern rheumatology
Published: September 28, 2022
Last Updated: 09/26/2026